| Christopher Dennis Ford, LSCSW | |
|
729 1/2 Massachusetts St, Suite 209, Lawrence, KS 66044-2345 | |
| (785) 423-4322 | |
| Not Available |
| Full Name | Christopher Dennis Ford |
|---|---|
| Gender | Male |
| Speciality | Clinical Social Worker |
| Experience | 17 Years |
| Location | 729 1/2 Massachusetts St, Lawrence, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043419401 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4321 (Kansas) | Primary |
| Entity Name | Bert Nash Community Mental Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841281805 PECOS PAC ID: 5799693834 Enrollment ID: O20040209000772 |
News Archive
"With its recently released Water and Development Strategy, USAID highlights some practical and potentially powerful initiatives both to improve health by expanding access to clean water and sanitation and to improve food security through better water management in agriculture," Isobel Coleman, a senior fellow for U.S. foreign policy and director of the Civil Society, Markets, and Democracy Initiative at the Council on Foreign Relations, writes in the council's "Democracy in Development" blog.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
The U.S. Food and Drug Administration (FDA) has cleared for U.S. marketing a vascular shunt, a medical device that can help save the arms and legs of soldiers critically injured in combat as well as individuals in other trauma settings and emergency situations.
› Verified 5 days ago
| Entity Name | Christopher Ford Lscsw Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134519341 PECOS PAC ID: 3971829300 Enrollment ID: O20150303000844 |
News Archive
"With its recently released Water and Development Strategy, USAID highlights some practical and potentially powerful initiatives both to improve health by expanding access to clean water and sanitation and to improve food security through better water management in agriculture," Isobel Coleman, a senior fellow for U.S. foreign policy and director of the Civil Society, Markets, and Democracy Initiative at the Council on Foreign Relations, writes in the council's "Democracy in Development" blog.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
The U.S. Food and Drug Administration (FDA) has cleared for U.S. marketing a vascular shunt, a medical device that can help save the arms and legs of soldiers critically injured in combat as well as individuals in other trauma settings and emergency situations.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Dennis Ford, LSCSW 729 1/2 Massachusetts St, Suite 209, Lawrence, KS 66044-2345 Ph: (785) 423-4322 | Christopher Dennis Ford, LSCSW 729 1/2 Massachusetts St, Suite 209, Lawrence, KS 66044-2345 Ph: (785) 423-4322 |
News Archive
"With its recently released Water and Development Strategy, USAID highlights some practical and potentially powerful initiatives both to improve health by expanding access to clean water and sanitation and to improve food security through better water management in agriculture," Isobel Coleman, a senior fellow for U.S. foreign policy and director of the Civil Society, Markets, and Democracy Initiative at the Council on Foreign Relations, writes in the council's "Democracy in Development" blog.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
The U.S. Food and Drug Administration (FDA) has cleared for U.S. marketing a vascular shunt, a medical device that can help save the arms and legs of soldiers critically injured in combat as well as individuals in other trauma settings and emergency situations.
› Verified 5 days ago
Rhonda Louise Dye, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 200 Maine St, Ste A, Lawrence, KS 66044 Phone: 785-843-9192 Fax: 785-843-6744 | |
Alex Michelle Kerr, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 200 Maine St Ste A, Lawrence, KS 66044 Phone: 785-843-9192 Fax: 785-843-6744 | |
Gwendolyn J Wiens, L.S.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 425 Rock Fence Pl, Lawrence, KS 66049 Phone: 785-749-5603 Fax: 785-832-1598 | |
Mr. John Howard Fittell, LSCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3109 W 6th St, Suite B, Lawrence, KS 66049 Phone: 785-979-2222 | |
Patricia Beard, LSCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 805 New Hampshire St Ste C, Lawrence, KS 66044 Phone: 785-838-5972 Fax: 852-124-0157 | |
Allison Faling, LSCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 719 Massachusetts St Ste 117, Lawrence, KS 66044 Phone: 785-218-6616 | |
Jennifer Ann De La Rosa, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2619 W 6th St Ste C, Lawrence, KS 66049 Phone: 785-615-1995 |